Parastoo Momeni

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID)
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, Building 35 Room 1A1010 35 Convent Drive, Bethesda, MD 20892, USA
    Neurobiol Aging 27:778.e1-778.e6. 2006
  2. ncbi request reprint Taiwanese cases of SCA2 are derived from a single founder
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20952, USA
    Mov Disord 20:1633-6. 2005
  3. pmc Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute of Aging, NIH, Bethesda, MD, USA
    BMC Neurol 6:44. 2006
  4. pmc Screening for C9ORF72 repeat expansion in FTLD
    Raffaele Ferrari
    Laboratory of Neurogenetics, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
    Neurobiol Aging 33:1850.e1-11. 2012
  5. pmc Clinical and pathological features of an Alzheimer's disease patient with the MAPT Delta K280 mutation
    Parastoo Momeni
    Laboratory of Neurogenetics, NIA, NIH Main Campus, Bethesda, MD 20892, USA
    Neurobiol Aging 30:388-93. 2009
  6. pmc Characteristics of frontotemporal dementia patients with a Progranulin mutation
    Edward D Huey
    Cognitive Neuroscience Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1440, USA
    Ann Neurol 60:374-80. 2006
  7. doi request reprint Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia
    Parastoo Momeni
    Texas Tech University Health Sciences Center, Department of Internal Medicine, Laboratory of Neurogenetics, Lubbock, TX 79430, USA
    Clin Neurol Neurosurg 112:917-20. 2010
  8. ncbi request reprint A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia
    Roneil Malkani
    Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, 35, Convent Drive, Bethesda, MD 20892, USA
    Neurobiol Dis 22:401-3. 2006
  9. ncbi request reprint Sequence analysis of all identified open reading frames on the frontal temporal dementia haplotype on chromosome 3 fails to identify unique coding variants except in CHMP2B
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, 35, Convent Drive, Bethesda, MD 20892, USA
    Neurosci Lett 410:77-9. 2006
  10. ncbi request reprint Frontal temporal dementia: dissecting the aetiology and pathogenesis
    John Hardy
    Laboratory of Neurogenetics, National Institute on Aging, National Institute of Mental Health, Porter Neuroscience Building, 35 Convent Drive, Bethesda, MD, USA
    Brain 129:830-1. 2006

Detail Information

Publications15

  1. ncbi request reprint Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID)
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, Building 35 Room 1A1010 35 Convent Drive, Bethesda, MD 20892, USA
    Neurobiol Aging 27:778.e1-778.e6. 2006
    ..To determine the molecular genetic contribution to this disease we performed a mutation analysis of all type IV neuronal IF, SOD1 and NUDEL genes in cases of NIFID and unaffected control cases. We found no pathogenic variants...
  2. ncbi request reprint Taiwanese cases of SCA2 are derived from a single founder
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20952, USA
    Mov Disord 20:1633-6. 2005
    ..In fact, our analysis showed that all SCA2 mutations carriers had the same ataxin 2 haplotype: haplotype B, which accounts for only 15% of control haplotypes, implying that there is a common founder for all Taiwanese SCA2 patients...
  3. pmc Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute of Aging, NIH, Bethesda, MD, USA
    BMC Neurol 6:44. 2006
    ..A new locus for amyotrophic lateral sclerosis--frontotemporal dementia (ALS-FTD) has recently been ascribed to chromosome 9p...
  4. pmc Screening for C9ORF72 repeat expansion in FTLD
    Raffaele Ferrari
    Laboratory of Neurogenetics, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
    Neurobiol Aging 33:1850.e1-11. 2012
    ..These findings are novel and need to be cautiously interpreted and most importantly replicated in larger numbers of samples...
  5. pmc Clinical and pathological features of an Alzheimer's disease patient with the MAPT Delta K280 mutation
    Parastoo Momeni
    Laboratory of Neurogenetics, NIA, NIH Main Campus, Bethesda, MD 20892, USA
    Neurobiol Aging 30:388-93. 2009
    ..Here we present the clinical and pathological features of a new case with this mutation and discuss whether the mutation is indeed pathogenic...
  6. pmc Characteristics of frontotemporal dementia patients with a Progranulin mutation
    Edward D Huey
    Cognitive Neuroscience Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1440, USA
    Ann Neurol 60:374-80. 2006
    ..The range of mutations of PGRN that can result in the FTD phenotype and the clinical presentation of patients with PGRN mutations have yet to be determined...
  7. doi request reprint Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia
    Parastoo Momeni
    Texas Tech University Health Sciences Center, Department of Internal Medicine, Laboratory of Neurogenetics, Lubbock, TX 79430, USA
    Clin Neurol Neurosurg 112:917-20. 2010
    ..It is likely that the early age at onset reflects a marked pathogenic effect of the mutation involving a disturbance of microtubule binding, tau phosphorylation or a major acceleration of tau aggregation...
  8. ncbi request reprint A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia
    Roneil Malkani
    Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, 35, Convent Drive, Bethesda, MD 20892, USA
    Neurobiol Dis 22:401-3. 2006
    ..This mutation sheds light on a novel mechanism by which over-expression of 4-repeat tau leads to disease. Based on our current findings, we propose a novel mechanism by which intronic mutations can lead to frontotemporal dementia...
  9. ncbi request reprint Sequence analysis of all identified open reading frames on the frontal temporal dementia haplotype on chromosome 3 fails to identify unique coding variants except in CHMP2B
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, 35, Convent Drive, Bethesda, MD 20892, USA
    Neurosci Lett 410:77-9. 2006
    ..We did not find any other unique variants. The implications of these findings for the likely mode of pathogenesis of frontal temporal dementia are discussed...
  10. ncbi request reprint Frontal temporal dementia: dissecting the aetiology and pathogenesis
    John Hardy
    Laboratory of Neurogenetics, National Institute on Aging, National Institute of Mental Health, Porter Neuroscience Building, 35 Convent Drive, Bethesda, MD, USA
    Brain 129:830-1. 2006
  11. pmc Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia
    Edward D Huey
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, Cognitive Neuroscience Section, Building 10, Room 7D43, MSC 1440, Bethesda, MD 20892 1440, USA
    Expert Opin Ther Targets 12:1367-76. 2008
    ..They are often fatal, and currently no medications have been shown to slow their progression. Recent developments in understanding these disorders may aid in developing treatments...
  12. ncbi request reprint Genetic variability in CHMP2B and frontotemporal dementia
    Parastoo Momeni
    Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA
    Neurodegener Dis 3:129-33. 2006
    ..The putative pathogenicity of CHMP2B mutations for dementia is discussed...
  13. doi request reprint Implication of common and disease specific variants in CLU, CR1, and PICALM
    Raffaele Ferrari
    Laboratory of Neurogenetics, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
    Neurobiol Aging 33:1846.e7-18. 2012
    ....
  14. ncbi request reprint Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative
    Rosa Rademakers
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Lancet Neurol 6:857-68. 2007
    ..The most common mutation in GRN is Arg493X. We aimed to establish the contribution of this mutation to FTLD and related disorders...
  15. ncbi request reprint Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome
    Mario Masellis
    Linda C Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre Toronto, Canada
    Brain 129:3115-23. 2006
    ..This report of mutation in the PGRN gene in CBS extends the evidence for genetic and phenotypic heterogeneity in FTLD spectrum disorders...